Exclusive Market Study Estimates that Vaccines Market will reach USD 48.0 Billion by 2025 | Sanofi Pasteur, GlaxoSmithKline (GSK), Merck, Pfizer, AstraZeneca, Emergent Biosolutions, Astellas Pharma, Sinovac

The exclusive research report on the Global Vaccines Market 2019 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global Vaccines Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

Global Vaccines Market Overview:

The Double Digit Growth Anticipated for Global Vaccines Market with Revenues likely to Reach USD 48.0 Billion during the forecast period 2019 – 2025.

The most important key factors driving the growth of the Global Vaccines Market are growing support for vaccine R&D, high prevalence of infectious diseases, investments into vaccine development, and a rising focus on immunization.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/162929 .

The Global Vaccines Market report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global vaccines market. The report explores detailed analysis of the top 42 vaccines market value assessment globally from 2015 to 2018 and forecasts to 2025. In addition, the report includes an assessment of promising vaccines in clinical development by major companies.

As per the geographic analysis, the North America is expected to dominate the Vaccines Market in 2018. The large share of this regional segment is attributed to factors such as increasing investments by government organizations and companies to promote immunization as well as develop new vaccines. Europe is expected to hold the second largest share of Vaccines Market. Factors such as availability of funding and venture capital investments for the development of new vaccines and increasing government initiatives are expected to drive market growth in this region.

Latest Business News:

1 GlaxoSmithKline (GSK) (April 29, 2019) – ViiV Healthcare submits New Drug Application to US FDA for the first monthly, injectable, two-drug regimen of cabotegravir and rilpivirine for treatment of HIV – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval for the investigational, monthly, injectable, two-drug regimen of ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine to treat HIV-1 infection in adults whose viral load is suppressed and who are not resistant to cabotegravir or rilpivirine.

The submission is based on the global ATLAS (Antiretroviral Therapy as Long-Acting Suppression) and FLAIR (First Long-Acting Injectable Regimen) pivotal phase III studies that included more than 1,100 patients from 16 countries and demonstrated the combination of cabotegravir and rilpivirine, injected monthly, was as effective as a standard of care, daily, oral, three-drug regimen in maintaining viral suppression throughout the 48-week study period. These results were presented in March at the 2019 Conference on Retroviruses and Opportunistic Infections.

Market Study:

1 Merck acquired Immune Design in 2019

2 Shingrix is set to achieve blockbuster vaccine status in 2019

3 Prevnar / Prevnar 13 has captured the highest market share of the global vaccines market

4 With a market value of more than US$ 7 billion, GSK led the global vaccines market in 2018

Top Leading Key Manufacturers are: Sanofi Pasteur, GlaxoSmithKline (GSK), Merck, Pfizer, AstraZeneca, Mitsubishi Tanabe Pharma, Emergent Biosolutions, Astellas Pharma Inc, Valneva, Seqirus, Bavarian Nordic, Sinovac, Panacea Biotec, Bharat Biotech, Serum Institute of India, Biological E Limited and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

With the presence of a large pool of participants, the Global Vaccines Market is displaying a highly competitive business landscape, finds a new research report by Business Industry Reports (BIR). Sanofi Pasteur, GlaxoSmithKline (GSK), Merck, Pfizer, AstraZeneca, Mitsubishi Tanabe Pharma, Emergent Biosolutions, Astellas Pharma Inc, Valneva, Seqirus, Bavarian Nordic, Sinovac, Panacea Biotec, Bharat Biotech, Serum Institute of India, etc. are some of the key vendors of Vaccines across the world. These players across Vaccines Market are focusing aggressively on innovation, as well as on including advanced technologies in their existing products.

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Vaccines in these regions, from 2013 to 2025 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Purchase this report online with 220 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Vaccines Market Report 2019” @ https://www.businessindustryreports.com/buy-now/162929/single .

Major Points in Table of Contents:

Global Vaccines Market Report 2019

1 ExecutiveSummary

2 Global Vaccines Market Size & Analysis (2015 - 2025)

3 Market Share Analysis of Global Vaccines Market (%), 2015 - 2025

3.1 Global Vaccines Market Share, By Brand

3.2 Global Vaccines Market Share, By Company

4 Key Drivers and Inhibitors of the Global Vaccines Market

4.1 Market Drivers

4.2 Market Inhibitors

5 Global Top 42 Vaccines Market Assessment & Opportunity (Value), 2015 - 2025

5.1 Prevnar / Prevnar 13

5.2 Gardasil / Gardasil 9

5.3 Vaxigrip

5.4 Fluzone

5.5 Flublok

5.6 Varivax

………………. Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.